Association between serum, mucosal and fecal infliximab levels and response to anti TNF-α therapy in patients with inflammatory bowel disease – new insights into the mechanism of loss of response to biological therapy  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
119809
Type K
Principal investigator Farkas, Klaudia
Title in Hungarian A szérum, a szöveti és a széklet infliximab szintek, valamint az anti TNF-α kezelésre adott válasz közötti korreláció vizsgálata gyulladásos bélbetegségekben - a biológiai terápia mellett fellépő hatásvesztés mechanizmusának új nézőpontjai
Title in English Association between serum, mucosal and fecal infliximab levels and response to anti TNF-α therapy in patients with inflammatory bowel disease – new insights into the mechanism of loss of response to biological therapy
Keywords in Hungarian gyulladásos bélbetegségek, anti-TNF terápia, hatásvesztés
Keywords in English inflammatory bowel disease, anti-TNF therapy, loss of response
Discipline
Public health, health services, environmental and occupational medicine, epidemiology, medical ethics (Council of Medical and Biological Sciences)100 %
Ortelius classification: Gastroenterology
Panel Immunity, Cancer and Microbiology
Department or equivalent First Department of Medicine (University of Szeged)
Participants Bálint, Anita
Bor, Renáta
Földesi, Imre
Madácsy, Tamara Éva
Maléth, József
Molnár, Tamás
Nagy, Ferenc
Starting date 2016-10-01
Closing date 2019-09-30
Funding (in million HUF) 28.113
FTE (full time equivalent) 5.50
state running project




Back »